|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - VERTEX PHARMACEUTICALS INC (VRTX)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2019-05-15 Sale |
2019-05-17 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
61 | $165.4 | $10,090 | 33,416 (Indirect Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:31 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M VP |
161 | $165.4 | $26,631 | 17,759 (Indirect Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:29 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
83 | $165.4 | $13,729 | 35,003 (Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
241 | $165.4 | $39,864 | 13,736 (Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
133 | $165.4 | $22,000 | 33,240 (Indirect Direct) |
View |
| 2019-05-15 Sale |
2019-05-17 4:16 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
91 | $165.4 | $15,052 | 31,553 (Direct) |
View |
| 2019-05-06 Sale |
2019-05-08 4:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
30,758 | $175 | $5,382,957 | 171,762 (Indirect Direct) |
View |
| 2019-05-03 Sale |
2019-05-06 4:08 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
1,829 | $172.9 | $316,220 | 37,332 (Direct) |
View |
| 2019-05-02 Sale |
2019-05-06 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
3,708 | $170.6 | $632,491 | 35,395 (Indirect Direct) |
View |
| 2019-05-01 Sale |
2019-05-03 4:06 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
10,480 | $175.1 | $1,834,826 | 202,820 (Indirect Direct) |
View |
| 2019-04-16 Sale |
2019-04-18 4:12 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
6,375 | $182 | $1,160,166 | 39,253 (Direct) |
View |
| 2019-04-15 Sale |
2019-04-17 4:30 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
5,624 | $181.7 | $1,022,148 | 36,272 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
2,812 | $187 | $525,747 | 18,903 (Indirect Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:26 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
5,624 | $187 | $1,051,585 | 36,003 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:24 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
20,997 | $187 | $3,926,113 | 110,095 (Indirect Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
1,488 | $186.9 | $278,163 | 14,038 (Direct) |
View |
| 2019-02-19 Sale |
2019-02-21 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
5,624 | $187 | $1,051,716 | 32,604 (Direct) |
View |
| 2019-02-12 Sale |
2019-02-13 4:40 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
35,095 | $180.1 | $6,319,216 | 64,692 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:39 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
111,431 | $180.2 | $20,083,803 | 223,916 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:37 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
33,073 | $180.2 | $5,959,969 | 61,280 (Indirect Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:36 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
32,956 | $180.2 | $5,939,188 | 60,050 (Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:33 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
12,136 | $180.2 | $2,187,190 | 48,869 (Direct) |
View |
| 2019-02-11 Sale |
2019-02-13 4:27 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,215 | $180.2 | $759,367 | 23,386 (Indirect Direct) |
View |
| 2019-02-07 Sale |
2019-02-07 4:04 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $193 | $248,777 | 13,938 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:51 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
12,722 | $186.9 | $2,377,296 | 48,817 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:50 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
18,309 | $186.2 | $3,409,083 | 54,711 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:49 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,247 | $187 | $794,273 | 16,896 (Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
32,250 | $186.3 | $6,009,682 | 155,815 (Indirect Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:46 pm |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
4,126 | $189.2 | $780,598 | 41,443 (Direct) |
View |
| 2019-02-04 Sale |
2019-02-06 4:45 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $189.2 | $440,813 | 38,489 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-05-06 Exercise |
2019-05-08 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
30,758 | $77.31 | 171,762 (Direct) |
View |
| 2019-05-06 Exercise |
2019-05-08 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
2,300 | $77.31 | 171,762 (Direct) |
View |
| 2019-05-06 Sale |
2019-05-08 4:10 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
2,300 | $175 | 171,762 (Direct) |
View |
| 2019-05-06 Exercise |
2019-05-08 4:10 pm |
N/A 2024-02-04 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
30,758 | $77.31 | 171,762 (Direct) |
View |
| 2019-05-06 Exercise |
2019-05-08 4:10 pm |
N/A 2024-02-04 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
2,300 | $77.31 | 171,762 (Direct) |
View |
| 2019-05-03 Exercise |
2019-05-06 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,329 | $86.52 | 37,332 (Direct) |
View |
| 2019-05-03 Sale |
2019-05-06 4:08 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
500 | $170.3 | 37,332 (Direct) |
View |
| 2019-05-03 Exercise |
2019-05-06 4:08 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,329 | $86.52 | 37,332 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 35,395 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,553 | $86.52 | 35,395 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:06 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 35,395 (Direct) |
View |
| 2019-05-02 Exercise |
2019-05-06 4:06 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,553 | $86.52 | 35,395 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
10,180 | $77.31 | 202,820 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
300 | $77.31 | 202,820 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:06 pm |
N/A 2024-02-04 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
10,180 | $77.31 | 202,820 (Direct) |
View |
| 2019-05-01 Exercise |
2019-05-03 4:06 pm |
N/A 2024-02-04 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
300 | $77.31 | 202,820 (Direct) |
View |
| 2019-04-16 Exercise |
2019-04-18 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
4,250 | $122.4 | 39,253 (Direct) |
View |
| 2019-04-16 Exercise |
2019-04-18 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,125 | $90.29 | 39,253 (Direct) |
View |
| 2019-04-16 Exercise |
2019-04-18 4:12 pm |
N/A 2026-01-03 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
4,250 | $122.4 | 39,253 (Direct) |
View |
| 2019-04-16 Exercise |
2019-04-18 4:12 pm |
N/A 2026-07-11 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,125 | $90.29 | 39,253 (Direct) |
View |
| 2019-04-15 Option Award |
2019-04-17 4:42 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
247 | $182.3 | 9,577 (Direct) |
View |
| 2019-04-10 Option Award |
2019-04-12 4:00 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR CFO |
3,697 | $0 | 9,532 (Direct) |
View |
| 2019-04-10 Option Award |
2019-04-12 4:00 pm |
N/A 2029-04-09 |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR CFO |
9,532 | $189.4 | 9,532 (Direct) |
View |
| 2019-02-21 Option Award |
2019-02-22 4:12 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
2,161 | $0 | 2,161 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
17,298 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
10,126 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
9,799 | $0 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:51 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
25,026 | $187.5 | 75,260 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
4,220 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
2,917 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
5,000 | $0 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:50 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
7,449 | $187.5 | 24,786 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
53,816 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
31,498 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
28,444 | $0 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:48 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M CEO |
72,647 | $187.5 | 238,623 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
8,438 | $0 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
8,166 | $0 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:43 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
20,855 | $187.5 | 52,763 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
3,516 | $0 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
9,799 | $0 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:39 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma EVP and CMO |
25,026 | $187.5 | 25,026 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
14,416 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
8,438 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
8,166 | $0 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:37 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
20,855 | $187.5 | 70,133 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
17,298 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
8,438 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
9,799 | $0 | 71,937 (Direct) |
View |
| 2019-02-06 Option Award |
2019-02-08 4:33 pm |
N/A 2029-02-05 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
25,026 | $187.5 | 71,937 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-07 4:04 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $91.05 | 13,938 (Direct) |
View |
| 2019-02-07 Exercise |
2019-02-07 4:04 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
1,289 | $91.05 | 13,938 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
1,942 | $86.52 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
2,155 | $91.05 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
1,942 | $86.52 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:51 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP, CRO |
2,155 | $91.05 | 48,817 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
4,250 | $109.4 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,554 | $86.52 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2025-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
4,250 | $109.1 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
2,155 | $91.05 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:50 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP\Chief Commercial Officer |
1,554 | $86.52 | 54,711 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:49 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
809 | $86.52 | 16,896 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:49 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Silva Paul M CFO |
809 | $86.52 | 16,896 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,796 | $91.05 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A 2026-02-01 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
1,796 | $91.05 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:46 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Global Research and CSO |
2,330 | $86.52 | 41,443 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:45 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $86.52 | 38,489 (Direct) |
View |
| 2019-02-04 Exercise |
2019-02-06 4:45 pm |
N/A 2027-02-02 |
VERTEX PHARMACEUTICALS INC | VRTX | Parini Michael VP |
2,330 | $86.52 | 38,489 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 23 May 2019 20:49:27 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |